Paris
France
51
2026-04-23
The entities that hold a legal rights for patent applications filed by inventor CHARNEAU Pierre:
Pierre CHARNEAU from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:
Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host
#2 | 2026-04-09POLYNUCLEOTIDES AND LENTIVIRAL VECTORS EXPRESSING NON-STRUCTURAL ANTIGENS OF A FLAVIVIRUS SELECTED FROM THE GROUP OF DENV, ZIKV AND YFV, INDUCING PROTECTIVE CD8+ T-CELL IMMUNITY IN A HOST
#3 | 2025-10-16LENTIVIRAL VECTORS TARGETING ANTIGENS TO MHC-II PATHWAY AND INDUCING PROTECTIVE CD8+ AND CD4+ T-CELL IMMUNITY IN A HOST
#4 | 2025-03-20BOOSTING SARS-COV-2 IMMUNITY WITH A LENTIVIRAL-BASED NASAL VACCINE
#5 | 2024-12-19LENTIVIRAL VECTOR FOR EXPRESSION OF HUMAN PAPILLOMAVIRUS (HPV) ANTIGENS AND ITS IMPLEMENTATION IN THE TREATMENT OF HPV INDUCED CANCERS
#6 | 2024-02-15HIGH THROUGHPUT METHODS AND PRODUCTS FOR SARS-COV-2 SERO-NEUTRALIZATION ASSAY
#7 | 2023-11-16LENTIVIRAL VECTORS ENABLING ROUTING ANTIGENS TO MHC-II PATHWAY AND INDUCING CD4+ AND CD8+ T-CELL RESPONSES IN A HOST
#8 | 2023-08-17SARS-COV-2 IMMUNOGENIC COMPOSITIONS, VACCINES, AND METHODS
#9 | 2021-06-24Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host
#10 | 2020-07-23Lentiviral vector-based Japanese encephalitis immunogenic composition
#11 | 2020-04-23Multiple malaria pre-erythrocytic antigens and their use in the elicitation of a protective immune response in a host
#12 | 2020-04-23Functional screening of antigenic polypeptides-use for the identification of antigens eliciting a protective immune response and for the selection of antigens with optimal protective activity
#13 | 2019-04-25LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA
#14 | 2018-12-06LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA
#15 | 2017-12-21USE OF NON-SUBTYPE B GAG PROTEINS FOR LENTIVIRAL PACKAGING
#16 | 2017-11-09Lentiviral vector-based Japanese encephalitis immunogenic composition
#17 | 2015-12-24Lentiviral vector based immunological compounds against malaria
#18 | 2015-07-09Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#19 | 2015-04-23Isolated and purified strains of Chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
#20 | 2015-01-08Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#21 | 2014-09-04Lentiviral gene transfer vectors and their medicinal applications
#22 | 2014-08-21Use of non-subtype B gag proteins for lentiviral packaging
#23 | 2014-02-20Cells and methodology to generate non-segmented negative-strand RNA viruses
#24 | 2013-07-04Lentiviral vector based immunological compounds against malaria
#25 | 2013-06-20Lentiviral vectors for the preparation of immunotherapeutical compositions
#26 | 2012-12-13Lentiviral gene transfer vectors and their medicinal applications
#27 | 2012-10-04Use of triplex structure DNA in transferring nucleotide sequences
#28 | 2012-10-04Use of triplex structure DNA in transferring nucleotide sequences
#29 | 2012-05-17Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#30 | 2012-05-17Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#31 | 2012-04-19Use of triplex structure DNA in transferring nucleotide sequences
#32 | 2012-04-05USE OF PROTEINS AND PEPTIDES ENCODED BY THE GENOME OF A NOVEL SARS-ASSOCIATED CORONAVIRUS STRAIN
#33 | 2011-10-13Lentiviral vectors for the preparation of immunotherapeutical compositions
#34 | 2011-08-25Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
#35 | 2011-06-28Lentiviral vectors for the preparation of immunotherapeutical compositions
#36 | 2011-04-14Lentiviral vector-based vaccine
#37 | 2011-03-17Strain of SARS-associated coronavirus and applications thereof
#38 | 2010-11-25Lentiviral gene transfer vectors and their medicinal applications
#39 | 2010-09-02Use of triplex structure DNA in transferring nucleotide sequences
#40 | 2010-06-10Cells and methodology to generate non-segmented negative-strand RNA viruses
#41 | 2010-03-04Novel Isolated And Purified Strains Of Chikungunya Virus And Polynucleotides And Polypetide Sequences, Diagnostic And Immunogenical Uses Thereof
#42 | 2010-02-04Lentiviral vector-based vaccine
#43 | 2009-08-27Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
#44 | 2008-10-23Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens
#45 | 2008-05-01BIPOTENTIAL LIVER CELL LINES FROM WILD-TYPE MAMMALIAN LIVER TISSUE
#46 | 2007-09-27Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
#47 | 2007-06-07Strain of SARS-associated coronavirus and applications thereof
#48 | 2007-04-19Lentiviral vector-based vaccine
#49 | 2007-01-02Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
#50 | 2006-02-23Use of triplex structure DNA in transferring nucleotide sequences
#51 | 2005-04-07Bipotential liver cell lines from wild-type mammalian liver tissue
299958 ⎘